We prospectively analyzed the intermediate-term results of thoracoscopic lung reduction performed unilaterally or bilaterally in selected patients with advanced emphysema. Unilateral lung reduction was performed intentionally in patients with asymmetric emphysema (n=21). Overall, among 39 patients operated on unilaterally, 13 subsequently underwent contralateral treatment during the follow-lip. One-stage bilateral lung reduction was intentionally performed in 8 patients with symmetric emphysema. Mortality rate was 2.1% (n=1) and morbidity rate was 36% (n=17). Mean hospital stay was 10.5 days. At 6 months, significant improvement was achieved as regards FEV1, FVC, dyspnea index, and six minute walk test, indipendently by the surgical approach. In particular FEV1 improved of 40% in unilaterally treated patients, whereas in the bilateral group FEV1 improved of 57% and 42% after one-stage or two-stage reduction, respectively. Both unilateral and bilateral thoracoscopic lung reduction can produce significant improvement in dyspnea, lung function and quality of life in properly selected patients.

Mineo, T.c., Pompeo, E., Depadova, F., Rogliani, P., Senis, L. (1998). Vats lung reduction in patients with advanced emphysema. In 2ND INTERNATIONAL CONGRESS OF THORAX SURGERY (pp.155-158). BOLOGNA : EDITRICE COMPOSITORI.

Vats lung reduction in patients with advanced emphysema

MINEO, TOMMASO CLAUDIO;POMPEO, EUGENIO;ROGLIANI, PAOLA;SENIS, LUCIA
1998-01-01

Abstract

We prospectively analyzed the intermediate-term results of thoracoscopic lung reduction performed unilaterally or bilaterally in selected patients with advanced emphysema. Unilateral lung reduction was performed intentionally in patients with asymmetric emphysema (n=21). Overall, among 39 patients operated on unilaterally, 13 subsequently underwent contralateral treatment during the follow-lip. One-stage bilateral lung reduction was intentionally performed in 8 patients with symmetric emphysema. Mortality rate was 2.1% (n=1) and morbidity rate was 36% (n=17). Mean hospital stay was 10.5 days. At 6 months, significant improvement was achieved as regards FEV1, FVC, dyspnea index, and six minute walk test, indipendently by the surgical approach. In particular FEV1 improved of 40% in unilaterally treated patients, whereas in the bilateral group FEV1 improved of 57% and 42% after one-stage or two-stage reduction, respectively. Both unilateral and bilateral thoracoscopic lung reduction can produce significant improvement in dyspnea, lung function and quality of life in properly selected patients.
2nd International Congress of Thorax Surgery
BOLOGNA, ITALY
JUN 24-26, 1998
Rilevanza internazionale
contributo
1998
Settore MED/21 - CHIRURGIA TORACICA
English
4
Intervento a convegno
Mineo, T.c., Pompeo, E., Depadova, F., Rogliani, P., Senis, L. (1998). Vats lung reduction in patients with advanced emphysema. In 2ND INTERNATIONAL CONGRESS OF THORAX SURGERY (pp.155-158). BOLOGNA : EDITRICE COMPOSITORI.
Mineo, Tc; Pompeo, E; Depadova, F; Rogliani, P; Senis, L
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/49820
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact